Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Barrett Esophagus × Spectrum Analysis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 2 Lung Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Cancer, Papillary 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Pleural Effusion, Malignant 1 Neoplasms 1 Lymphatic Metastasis 1 Kidney Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Barrett Esophagus 1 Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy 14 Endoscopy, Digestive System 12 Biopsy 9 Specimen Handling 6 Radiofrequency Ablation 6 Gastroscopy 6 Esomeprazole 6 Endoscopic Mucosal Resection 6 Aspirin 4 Proflavine 3 Omeprazole 3 Narrow Band Imaging 3 Diagnostic Imaging 3 Breath Tests 3 YF 476 2 Proton Pump Inhibitors 2 Photochemotherapy 2 Microscopy, Confocal 2 Metformin 2 Lansoprazole 2 Itraconazole 2 Endoscopes 2 Dexlansoprazole 2 Cryotherapy 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 rofecoxib 1 polyphenon E 1 omeprazole, sodium bicarbonate drug combination 1 obeticholic acid 1 gluconic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05745857 2023-02-27

SLURP

University Medical Center Groningen

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡